The deployment of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) and other vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in a significant decrease in mortality due to coronavirus disease 2019 (Covid-19).